During clarithromycin coadministration, four out of the seven patients developed moderate-to-severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
ataxia
carbamazepine
toxic symptoms
clarithromycin
dizziness
carbamazepine
drowsiness
carbamazepine
toxic symptoms
carbamazepine
dizziness
clarithromycin
ataxia
clarithromycin
drowsiness
clarithromycin